Related Experiment Video
Updated: Mar 15, 2026
07:35
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
12.1K
Genetic Considerations in Pediatric Chronic Kidney Disease
Lyndsay A Harshman1, Diana Zepeda-Orozco1
1Division of Pediatric Nephrology, Stead Family Department of Pediatrics, University of Iowa Children's Hospital, Iowa City, Iowa, United States.
Journal of Pediatric Genetics
|September 13, 2016
Summary
Genetic and epigenetic factors significantly influence childhood chronic kidney disease (CKD) progression. Understanding these genetic underpinnings can help identify at-risk children and develop targeted therapies for CKD.
Area of Science:
- Pediatric Nephrology
- Genetics
- Epigenetics
Background:
- Childhood chronic kidney disease (CKD) is irreversible, often stemming from congenital disorders.
- Genetic and epigenetic factors play a crucial role in CKD progression.
- CKD can lead to end-stage renal disease and cardiovascular complications.
Purpose of the Study:
- To explore the genetic and epigenetic contributions to the progression of childhood CKD.
- To identify genetic variants and epigenetic modifications influencing CKD development and severity.
- To understand how genetic and epigenetic factors impact cardiovascular and renal complications in pediatric CKD.
Main Methods:
- Utilized gene-mapping strategies, including genome-wide association studies (GWAS).
- Analyzed single-nucleotide polymorphisms (SNPs) to identify genetic variants.
- Examined epigenetic modifications such as DNA methylation, histone modification, and RNA interference.
Main Results:
- GWAS identified loci associated with CKD progression in population data.
- SNPs analysis linked CKD sequelae to cardiovascular-inflammatory axis dysfunction and renal interstitial fibrosis.
- Epigenetic studies highlighted the influence of environmental factors on genomic expression in CKD.
Conclusions:
- Genetic and epigenetic insights are vital for understanding childhood CKD progression.
- Identifying genetic variants and epigenetic modifications can predict accelerated disease risk.
- This knowledge may facilitate the development of novel, targeted therapies for pediatric CKD.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
952
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
952
01:28Chronic Kidney Disease III: Interprofessional Care
578
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
578
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
01:24Chronic Kidney Disease II: Clinical Manifestations
876
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
876
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
01:28Kidney Transplant I: Introduction
646
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
646